VR Logo

Eris Lifesciences: Board Meeting Outcome for OUTCOME OF THE BOARD MEETING


The Board of Directors of the Company at their meeting held today i.e. January 28 2022 duly approved and took on record the limited reviewed Unaudited Standalone Financial Results and the limited reviewed Unaudited Consolidated Financial Results of the Company for the quarter and nine months ended December 31 2021.

Click here to view PDF